Neuropsychological functioning in a cohort of HIV infected women: Importance of antiretroviral therapy

Journal of the International Neuropsychological Society

Volumn 8, Issue 6, 2002, Pages 781-793

  Richardson, Jean L ^a   Martin, Eileen M ^a   Jimenez, Nora ^a   Danley, Kathleen ^a   Cohen, Mardge ^a   Carson, Valories L ^a   Sinclair, Barbara ^a   Racenstein, J Meg ^a   Reed, Robyn A ^a   Levine, Alexandra M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

AIDS; Antiretroviral therapy; Dementia; HIV; Memory; Neuropsychological tests; Neuropsychology; Women; Women's health; Zidovudine

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; LAMIVUDINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ACADEMIC ACHIEVEMENT; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISTRESS SYNDROME; DRUG DEPENDENCE; ETHNOLOGY; FEMALE; HEAD INJURY; HELPER CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTELLIGENCE QUOTIENT; LYMPHOCYTE COUNT; MENTAL DISEASE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGY; PERFORMANCE; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 20244377353     PISSN: 13556177     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1355617702860064     Document Type: Article

References (49)

1. Ammons, R.B. & Ammons, C.H. (1962). The Quick Test (QT) Provisional manual. Psychological Reports, 11, 111-161.
2. Baldeweg, T., Catalan, J., Lovett, E., Gruzelier, J., Riccio, M., & Hawkins, D. (1995). Long-term zidovudine reduces neurocognitive deficits in HIV-1 infection. AIDS, 9, 589-596.
3. Barkan, S., Melnick, S., Preston-Martin, S., Weber, K., Kalish, L., Miotti, P., Young, M., Padian, N., Sacks, H., & Feldman, J. (1998). The Women's Interagency HIV Study (WIHS): Design, methods, sample, cohort characteristics and comparison with reported AIDS cases in women. Epidemiology, 9, 117-125.
4. Bornstein, R.A., Nasrallah, H.A., Para, M.F., Whitacre, C.C., Rosenberger, P., & Fass, R.J. (1993). Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS, 7, 519-524.
5. Brouwers, P., Moss, H., Wolters, P., Eddy, J., Balis, F., Poplack, D.G., & Pizzo P.A. (1990). Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection. Journal of Pediatrics, 117, 980-985.
6. Bruisten, S., van Gemen, B., Koppelman, M., Rasch, M., Van Strijp, D., Schukkink, R., Beyer, R., Weigel, H., Lens P., & Huisman, H. (1993). Detection of HIV-1 distribution in different blood fractions by two nucleic acid amplification assays. AIDS Research and Human Retroviruses, 9, 259-265.
7. Centers for Disease Control. (1992). Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection. Morbidity and Mortality Weekly Report, 41, 1-17.
8. Chiesi, A., Vella, S., Dally, G., Pedersen, C., Danner, S., Johnson, A.M., Schwander, S., Goebel, F.D., Glauser, M., & Antunes, F. (1996). Epidemiology of AIDS Dementia Complex in Europe. AIDS in Europe Study Group. Journal of Acquired Immune Deficiency Syndromes, 11, 39-44.
9. Cohen, R.A., Boland, R., Paul, R., Tashima, K.T., Schoenbaum, E.E., Celentano, D.D., Schuman, P., Smith, D.K., & Carpenter, C.C. (2001). Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS, 15, 341-345.
10. Damos, D.L., John, R.S., Parker, E.S., & Levine, A.M. (1997). Anti-retroviral therapy and cognitive function. Aviation, Space, and Environmental Medicine, 68, 900-906.
11. D'Elia, L.F., Satz, P., Uchiyama, C.L., & White, T. (1994). Color Trails Test: Professional manual. Lutz, FL: Psychological Assessment Resources.
12. Durvasula R.S., Miller, E.N., Myers H.F., & Wyatt G.E. (2001). Predictors of neuropsychological performance in HIV positive women. Journal of Clinical and Experimental Neuropsychology, 23, 149-163.
13. Ellis, R.J., Hsia K., Spector, S.A., Nelson, J.A., Heaton, R.K., Wallace, M.R., Abramson, I., Atkinson, J.H., Grant, L, & McCutchan, J.A. (1997). Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Annals of Neurology, 42, 679-688.
14. Elovaara, I., Poutiainen, E., Lahdevirta, J., Hokkanen L., Raininko, R., Mattinen, S., Virta, A., Suni, J., & Ranki, A. (1994). Zidovudine reduces intrathecal immunoactivation in patients with early human immunodeficiency virus Type 1 infection. Archives, of Neurology, 51, 943-950.
15. Ferrando, S., van Gorp, W., McElhinney, M., Goggin, K., Sewell, M., & Rabkin, J. (1998). Highly active antiretroviral treatment in HIV infection: Benefits for neuropsychological function. AIDS, 12, F65-F70.
16. Fox-Tierney, R.A., Ickovics, J.R., Cerreta, C.L., & Ethier, K.A. (1999). Potential sex differences remain understudied: A case study of the inclusion of women in HIV/AIDS-related neuropsychological research. Review of General Psychology, 3, 44-54.
17. Goggin K.J., Zisook S., Heaton R.K., Atkinson J.H., Marshall S., McCutchan J.A., Chandler J.L., & Grant, I. (1997). Neuropsychological performance of HIV-1 infected men with major depression. Journal of the International Neuropsychological Society, 3, 457-464.
18. Guinan, M.E. & Leviton, L. (1995). Prevention of HIV infection in women: Overcoming barriers. Journal of the American Medical Women's Association, 50, 74-77.
19. Heaton, R.K., Grant, I., Butters, N., White, D.A., Kirson, D., Atkinson, J.H., McCutchan, J.A., Taylor, M.J., Kelly, M.D., & Ellis, R.J. (1995). The HNRC 500: Neuropsychology of HIV infection at different disease stages. Journal of the International Neuropsychological Society, 1, 231-251.
20. Heaton, R.K., Marcotte, T.D., White, D.A., Ross, D., Meredith, K., Taylor, M.J., Kaplan, R., & Grant, I. (1996). Nature and vocational significance of neuropsychological impairment associated with HIV infection. Clinical Neuropsychologist, 10, 1-14.
21. Kløve, H. (1963). Clinical neuropsychology. In F.M. Forster (Ed.), Medical clinics of North America. New York: WB Saunders.
22. Lezak, M.D. (1995). Neuropsychological assessment (3rd ed.), New York: Oxford University Press.
23. Maj, M., D'Elia, L.F., Satz, P., Janssen, R., Zaudig, M., Uchiyama, C., Starace, F., Galderisi, S., & Chervinsky, A. (1993). Evaluation of two neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: A WHO study. Archives of Clinical Neuropsychology, 8, 123-135.
24. Marder, K., Stern, Y., Malouf, R., Tang, M., Bell, K., Dooneief, G., El-Sadr, W., Goldstein, S., Gorman, J., & Richards, M. (1992). Neurological and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users with acquired immunodeficiency syndrome: Relationship to head injury. Archives of Neurology, 49, 1169-1175.
25. Martin, E.M., Pitrak, D.L., Pursell, K.J., Andersen, B.R., Mullane, K.M., & Novak, R.M. (1998). Information processing and antiretroviral therapy in HIV-1 infection. Journal of the International Neuropsychological Society, 4, 329-335.
26. Martin, E.M., Cook, J.A., Cohen, M., Carson, V., Reed, R., Hershow, R., & Burke, J. (1999a). Working memory in HIV-seropositive women: The Women's Interagency HIV Study [Abstract]. Journal of the International Neuropsychological Society, 5, 155.
27. Martin, E.M., Pitrak, D.L., Novak, R.M., Pursell, K.J., & Mullane, K.M. (1999b). Reaction times are faster in HIV-seropositive patients on antiretroviral therapy: A preliminary report. Journal of Clinical and Experimental Neuropsychology, 21, 730-735.
28. Mason, K.I., Campbell, A., Hawkins, P., Madhere, S., Johnson, K., & Takushi-Chinen, R. (1998). Neuropsychological functioning in HIV-positive African American women with a history of drug use. Journal of the National Medical Association, 90, 665-674.
29. Matthews, C.G. & Kløve, H. (1964). Instruction manual for the Adult Neuropsychology Test Battery. Madison, WI: University of Wisconsin Medical School.
30. McArthur, J.C., & Grant, I. (1997). HIV neurocognitive disorders. In H.E. Gendelman, S.A. Lipton, & L. Epstein (Eds.), The neurology of AIDS (pp. 499-523). New York: Chapman and Hall.
31. McArthur, J.C., Hoover, D.R., Bacellar, H., Miller, E.N., Cohen, B.A., Becker, J.T., Graham, N.M., McArthur, J.H., Selnes, O.A., Jacobson, L.P., Visscher, B.R., Concha, M., Saah, A., & the Multicenter AIDS Cohort Study. (1993). Dementia in AIDS patients: Incidence and risk factors. Neurology, 43, 2245-2252.
32. Miller, E.N., Selnes, O.A., McArthur, J.C., Satz, P., Becker, J.T., Cohen, B.A., Sheridan, K., Machado, A.M., van Gorp, W.F., & Visscher, B. (1990). Neuropsychological performance in HIV-1 infected homosexual men: The Multicenter AIDS Cohort Study (MACS). Neurology, 40, 197-203.
33. Racenstein, J.M., Martin, E.M., Reed, R.A., Carson, V.L., Harris, T.E., Sullivan, T.S., & Cohen, M. (October, 1999). Gender differences in auditory working memory in HIV positive individuals. Paper presented at the National Conference on Women and HIV/AIDS: Program and Abstracts. Pasadena, California.
34. Racenstein, J.M., Martin, E.M., Reed, R., Carson, V. Staley, K., & Cohen, M. (February, 2001). Cognitive reserve and neuropsychological performance of HIV-seropositive women. Paper presented at the 29th Annual International Neuropsychological Conference. Denver, Colorado.
35. Reinvang, I., Froland, S.S., Karlesen, N.R., & Lundervold, A.J. (1991). Only temporary improvement in impaired neuropsychological function in AIDS patient treated with zidovudine. AIDS, 5, 228-229.
36. Sacktor, N.C., Lyles, R.H., Skolasky, R.L., Anderson, D.E., McArthur, J.C., McFarlane, G., Selnes, O.A., Becker, J.T., Cohen, B., Wesch, J., & Miller, E.N. (1999). Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Neurology, 52, 1640-1647.
37. Satz, P., Morgenstern, H., Miller, E.N., Selnes, O.A., McArthur, J.C., Cohen, B.A., Wesch, J., Becker, J.R., Jacobson, L., D'Elia, L.F., van Gorp, W., & Visscher, B. (1993). Low education as a possible risk factor for cognitive abnormalities in HIV-1: Findings from the Multicenter AIDS Cohort Study (MACS). Journal of Acquired Immune Deficiency Syndrome, 6, 503-511.
38. Semple, S, Patterson, T., Temoshok, L, McCutchan, J., Straits-Troster, K.A., Chandler, J.L., & Grant, I. (1993). Identification of psychobiological stressors among HIV-positive women.
39. Schmitt, F., Bigley, J., McKinnis, R., Logue, P.E., Evans, R.W., Drucker, J.L., & the AZT Collaborative Work Group. (1988). Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine, 319, 1573-1578.
40. Sidtis, J.J., Gatsonis, C., Price, R.E.W., Singer, E.J., Collier, A.C., Richman, D.D., Hirsch, M.S., Schaerf, F.F.W., Fischl, M.A., Kieburtz, K., Simpson, D., Koch, M.A., Feinberg, J., Dafni, U., & the AIDS Clinical Trials Group. (1993). Zidovudine treatment of the AIDS dementia complex: Results of a placebo-controlled trial. Annals of Neurology, 33, 343-349.
41. Smith, A. (1982). Symbol Digit Modalities Test manual. Los Angeles, CA: Western Psychological Services.
42. Stern, R.A., Arruda, J.E., Somerville, J.A., Cohen, R.A., Boland, R.J., Stein, M.D., & Martin, E.M. (1998). Neurobehavioral functioning in asymptomatic HIV-1 infected women. Journal of the International Neuropsychological Society, 4, 172-178.
43. Teng, E.L. (1994). The Mental Alternations Test (MAT). Unpublished manuscript.
44. Tross, S., Price, R.W., Navia, B., Thaler, H.T., Gold, J., Hirsch, D.A., & Sidtis, J.J. (1988). Neuropsychological characterization of the AIDS dementia complex: A preliminary report. AIDS, 2, 81-88.
45. Vandamme, A.M., Schmit, J.C., VanDooren, S., Van Laethem, K., Gobbers, E., Kok, W., Goubau, P., Witvrouw, M., Peetermans, W., DeClercq, E., & Desmyter, J. (1996). Quantification of HIV-1 RNA in plasma: Comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV Monitor Test. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 13, 127-139.
46. van Gorp, W.G., Hinkin, C.H., Moore, L.H., Miller, E.M., Marcotte, T.D., Satz, P., & Weisman, J. (1995). Ascertainment bias and neuropsychological performance in HIV-1 disease. Neuropsychology, 9, 206-210.
47. Wechsler, D. (1987). Wechsler Memory Scale-Revised manual. New York: The Psychological Corporation.
48. Weissman, M.M., Sholomskas, D., Pottenger, M., Prusoff, B.A., & Locke, B.Z. (1977). Assessing depressive symptoms in five psychiatric populations: A validation study. American Journal of Epidemiology, 106, 203-214.
49. Yen-Lieberman, B., Brambilla, D., Jackson, B., Bremer, J., Coombs, R., Cronin, M., Herman, S., Katzenstein, D., Leung, S., Lin, H.J., Palumbo, P., Rasheed, S., Todd, J., Vahey, M., & Reichelderfer, P. (1996). Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type-1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. Journal of Clinical Microbiology, 34, 2695-2701.